Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. (Q40100311)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q59678623)
(Q1769254)
(P304) 911-920
(P433) 8
(P478) 25
(P577) Sunday, July 29, 2007
(P1433) (Q1893837)
(P1476) "Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells" (language: en)
(P2093) Farbod Shojaei
Xiumin Wu
Cuiling Zhong
Megan E Baldwin
Stefanie Schanz
Germaine Fuh
Hans-Peter Gerber
(P2860) (Q34382998)
(Q54692960)
(Q35222185)
(Q27860704)
(Q34549887)
(Q29615445)
(Q34520330)
(Q29547317)
(Q36328565)
(Q43740963)
(Q42798992)
(Q50128020)
(Q34428099)
(Q28203327)
(Q59276609)
(Q58043095)
(Q34732381)
(Q45987670)
(Q24535043)
(Q37426670)
(Q51152202)
(Q45934495)
(Q33763790)
(Q37358006)
(Q77753940)
(Q35318845)
(Q34134083)
(Q58880798)
(Q29620412)
(Q29615427)
(Q72759216)
(Q40943449)
(Q36113777)
(Q29622818)
(Q34354300)
(Q36243741)
(Q33226862)
(Q39959426)
(Q52038297)
(Q44043571)
other details
description scientific article

External Links